Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETELCALCETIDE vs ETESEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ETELCALCETIDE vs ETESEVIMAB: Safety Overview

Metric ETELCALCETIDE ETESEVIMAB
Total FAERS Reports 2,746 1,188
Deaths Reported 321 67
Death Rate 11.7% 5.6%
Hospitalizations 762 374
Average Patient Age 64.0 yrs 54.0 yrs
% Female Patients 44.2% 61.7%
FDA Approval Date Feb 7, 2017 N/A
Manufacturer Amgen Inc N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A